All times listed are Eastern Standard Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.
- Home
-
Saturday, Nov 16th
10:00 AM – 11:30 AM Eastern Time16S15: GRASPing and cGASing at SSc Pathogenesis: Molecular Insights into Centromeres, Genes, and BeyondLocation: Room 144ABC
Moderator: – Medical University of South Carolina
Moderator: – UTHealth Houston Division of Rheumatology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:00 AM – 10:30 AM Eastern TimeGenetic Insights Into African American Scleroderma: The GRASP ProjectLocation: Room 144ABC
Speaker: – National Institutes of Health
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 11:00 AM Eastern TimeThe Single-Cell Transcriptome Across Time and Autoantibody Subtype in SScLocation: Room 144ABC
Speaker: – University of Oxford
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
11:00 AM – 11:30 AM Eastern TimeCentromeres and cGAS/STING Pathway in SSc PathogenesisLocation: Room 144ABC
Speaker: – University of Alabama at Birmingham
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 11:30 AM Eastern Time16S18: Into the Weeds: Bringing the Science of Cannabis to the Rheumatology PatientLocation: Room 150AB
Moderator: – University of Pennsylvania
Moderator: – University of Nebraska Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 11:00 AM Eastern TimeThe Science of Medical Cannabis for Management of Chronic Pain in Rheumatic DiseasesLocation: Room 150AB
Speaker: – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
11:00 AM – 11:30 AM Eastern TimeBridging the Pain Gap: Applications of Medical Cannabis in Rheumatology ClinicLocation: Room 150AB
Speaker: – University of Iowa Hospitals and Clinics
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern TimeSystemic Sclerosis & Related Disorders – Clinical Poster IFibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0677: Patterns of Raynaud’s Phenomenon Management in Patients with Systemic Sclerosis: A Real-World Data from Community-Based Practices in the United StatesAbstract Poster Presenter: – University of Iowa Health Care
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0678: Patients with Interstitial Lung Disease Due to Systemic Sclerosis or Rheumatoid Arthritis Need Monitoring More Frequently Than AnnuallyAbstract Poster Presenter: – Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0679: Comparing Raynaud’s Phenomenon Measurement Tools: Results of the Optimizing Raynaud Phenomenon Outcome Measures in Systemic Sclerosis (ROSS) StudyAbstract Poster Presenter: – Johns Hopkins University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0680: Clinical Correlates of Physical and Mental Health in Early Systemic Sclerosis: Data from the Collaborative National Quality and Efficacy (CONQUER) RegistryAbstract Poster Presenter: – Mayo Clinic, Rochester, MN
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0681: Influence of Occupational Exposure to Pollutants on Clinical and Serological Phenotypes in Systemic SclerosisAbstract Poster Presenter: – Hospital del Mar
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0682: Results from Outcomes Selection and Development of a Patient-reported Outcome Measure for a Combined Response Index for Limited Cutaneous SSc: The CRISTAL ProjectAbstract Poster Presenter: – CHU Rennes - University Rennes
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0683: Prognostic Value of Systemic Sclerosis-associated Primary Heart InvolvementAbstract Poster Presenter: – University Hospital Zurich, University of Zurich
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0684: The Diagnostic Accuracy of Ultrasound for Low Muscle Mass in Women with Systemic SclerosisAbstract Poster Presenter: – Universidade Federal do Rio Grande do Sul
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0685: KL-6 and IL-18 Biomarkers in Systemic Sclerosis-associated Interstitial Lung Disease: Enhancing Prognostic Insights into Early Detection, Progression, Lung Volume Changes,and Mortality RiskAbstract Poster Presenter: – Complejo Asistencial Universitario de León
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0686: The Role of Inflammation in Systemic Sclerosis: CRP-Associated Phenotypes and Prognostic ImplicationsAbstract Poster Presenter: – Complejo Asistencial Universitario de León
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0687: Patterns of Disease Progression in Early Systemic Sclerosis Patients with Interstitial Lung DiseaseAbstract Poster Presenter: – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0688: Mycophenolate Mofetil Treatment in Limited Cutaneous Systemic Sclerosis Reduces the Risk of Vascular Complication Leading to Treatment Escalation: Emulation of a Target Trial Using Time-dependent Propensity Score-matchingAbstract Poster Presenter: – Catholic University of the Sacred Heart
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0689: Arrhythmic Burden, Myocardial Markers, and Long-term Survival in Distinct Cardiac Magnetic Resonance Subsets of Systemic SclerosisAbstract Poster Presenter: – Catholic University of the Sacred Heart
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0690: Can Immunosuppression or Vasodilation Prevent the Onset of Interstitial Lung Disease in Systemic Sclerosis? An Association Analysis from the EUSTAR DatabaseAbstract Poster Presenter: – University of Zurich
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0691: Predictors of Response and Long-term Efficacy and Safety of Nintedanib in Systemic Sclerosis-Interstitial Lung Disease: Data from an Italian Multicentre StudyAbstract Poster Presenter: – IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0692: Evaluation of the New Criteria for Progressive Pulmonary Fibrosis in Patients with Systemic SclerosisAbstract Poster Presenter: – Complejo Asistencial Universitario de León
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0693: Behind the Bronchiectasis in Systemic Sclerosis. Prevalence and Risk FactorsAbstract Poster Presenter: – Complejo Asistencial Universitario de León
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0694: A Unified Vascular Phenotype Score Identifies Systemic Sclerosis Endotypes and Predicts Prognostic Outcomes: Results from the EUSTAR DatabaseAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0695: Prognostic Value of Serum Type I Interferon in Predicting Morbi-Mortality Outcomes in Systemic Sclerosis: Insights from the STRIKE Basket CohortAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0696: MRI DAVIX Index Is an Imaging Biomarker for Endothelial Damage of Systemic Sclerosis Digital UlcersAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0697: Association of ANCA-Associated Vasculitis and Development of SSc and SSc-Associated Antibodies: Impact of Pulmonary Arterial HypertensionAbstract Poster Presenter: – Creighton University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0698: Association of Systemic Sclerosis with ANCA-Associated Vasculitis and Large Vessel Vasculitis: Impact of Pulmonary Arterial HypertensionAbstract Poster Presenter: – Creighton University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0700: Prospective Evaluation of Capillaroscopy in Healthy ChildrenAbstract Poster Presenter: – University Hospital Ghent
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0701: Diagnostic Performances of Vascular Biomarkers Soluble Fms-like Tyrosine Kinase (sFlt-1) and Placental Growth Factor (PlGF) in Scleroderma Renal Crisis: A Case Control StudyAbstract Poster Presenter: – Université Paris Cité
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0702: AISA 021, a Novel Calcium Channel Antagonist in Development for Raynaud's & Systemic Sclerosis, Has Antagonistic Activity at Sodium Channel Targets for Pain Relief and Treats Scleroderma Pain Better Than Current Calcium Channel Blockers in a Phase 2A StudyAbstract Poster Presenter: – Tufts University Medical Center and Aisa Pharma, Inc.
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0703: Preliminary Results from the RECONNOITER Trial, a Phase 2 Study of AISA 021 in the Treatment of Secondary Raynaud's, Primarily Due to Systemic SclerosisAbstract Poster Presenter: – Tufts University Medical Center and Aisa Pharma, Inc.
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0704: Progression of Global Longitudinal Strain and Identification of Left Ventricular Dysfunction in Systemic Sclerosis PatientsAbstract Poster Presenter: – Cleveland Clinic
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0705: Identification of Risk Factors for Incident Cardiomyopathy in Patients with Systemic SclerosisAbstract Poster Presenter: – Johns Hopkins University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0706: Single Center Prospective Cohort of Systemic Sclerosis Patients Who Are At-Risk for Pulmonary HypertensionAbstract Poster Presenter: – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0707: Comprehensive Skin Assessment in Systemic Sclerosis Using Spatial Frequency Domain Imaging (SFDI)Abstract Poster Presenter: – Department of Biomedical Engineering, Boston University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0708: Outcomes of Intermittent Intravenous Steroid Use During Infusion Therapy in Systemic SclerosisAbstract Poster Presenter: – University of New Mexico
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0709: Linear Combination of Principal Components Achieves Top Performance in Identifying Rheumatologist-Diagnosed Systemic Sclerosis from Electronic Health RecordsAbstract Poster Presenter: – Columbia University Irving Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0710: High S100A4 Levels Associate with Inflammation and Vasculopathy in Systemic SclerosisAbstract Poster Presenter: – Inselspital, Universitätsklinik Bern
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0711: Molecular Signatures in the Skin as Predictors of Longitudinal Clinical Trajectories in Patients with Systemic SclerosisAbstract Poster Presenter: – Northwestern Memorial Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0712: Efficacy of Sacubitril/Valsartan in Patients with Systemic Sclerosis and Heart Failure: A Retrospective AnalysisAbstract Poster Presenter: – Mayo Clinic Arizona
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time0713: Anti-muscarinic 3 Antibodies in SSc Associate with a More Significant GI and Extraintestinal Clinical PhenotypeAbstract Poster Presenter: – McGovern Medical School at UTHSC
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
1:00 PM – 2:00 PM Eastern Time16S26: CARE to Test Your Knowledge: Retroperitoneal FibrosisLocation: Ballroom A
Moderator: – Johns Hopkins
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
1:00 PM – 2:00 PM Eastern TimeCARE: Retroperitoneal FibrosisLocation: Ballroom A
Speaker: – Massachusetts General Hospital , Harvard Medical School
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
1:00 PM – 2:30 PM Eastern Time16S56: Abstracts: Systemic Sclerosis & Related Disorders – Basic ScienceLocation: Room 143ABC
Abstract Moderator: – Geisel School of Medicine at Dartmouth
Abstract Moderator: – Hospital for Special Surgery
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
1:00 PM – 1:15 PM Eastern Time0781: An Expanded Cytotoxic CD8 T Cell Population Regulated by CD155-CD226 in SSc-ILDLocation: Room 143ABC
Presenting Author: – Brigham and Women's Hospital and Harvard Medical School
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
1:15 PM – 1:30 PM Eastern Time0782: 30-Color Full Spectrum Flow Cytometry Identifies Sex Differences in the Circulating Immune Landscape of Systemic SclerosisLocation: Room 143ABC
Presenting Author: – Hospital of the University of Pennsylvania
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
1:30 PM – 1:45 PM Eastern Time0783: Spatial Reconstruction of Interstitial Lung DiseaseLocation: Room 143ABC
Presenting Author: – Brigham and Women's Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
1:45 PM – 2:00 PM Eastern Time0784: RUNX1 Is Expressed in a Subpopulation of Dermal Fibroblasts and Is Increased with Systemic Sclerosis Disease SeverityLocation: Room 143ABC
Presenting Author: – Geisel School of Medicine at Dartmouth
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
2:00 PM – 2:15 PM Eastern Time0785: Exploring the Link Between Atgl-Dependent Lipolysis and Dermal Fibrosis in Systemic SclerosisLocation: Room 143ABC
Presenting Author: – Yale School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Saturday, Nov 16th
2:15 PM – 2:30 PM Eastern Time0786: First Analyses of Transcriptomic Changes in the Skin of SSc Patients upon CD19-targeting CAR T Cell TherapyLocation: Room 143ABC
Presenting Author: – University Hospital Erlangen, Medicine 3
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern TimeSystemic Sclerosis & Related Disorders – Basic Science Poster IFibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern TimeSystemic Sclerosis & Related Disorders – Clinical Poster IIFibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0951: A Feedback Loop Involving mtDNA, Platelets and Neutrophil Extracellular Traps Amplifies Inflammation in Systemic SclerosisAbstract Poster Presenter: – Basel University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0952: Single Cell RNA-seq of Scleroderma-associated Interstitial Lung Disease Lung Explants Reveals an Active, Cytotoxic Natural Killer Cell PopulationAbstract Poster Presenter: – University of Pittsburgh Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0953: Establishment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension Specific Endothelial Cells Through iPSCs and Their Functional and Molecular AnalysesAbstract Poster Presenter: – Hokkaido U - Rheumatology, Endocrinology and Nephrology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0954: Increased Proliferating Natural Killer Cells Exhibit an Aberrant Pro-Inflammatory Gene Signature in Systemic Sclerosis PatientsAbstract Poster Presenter: – Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich & Campus Bio-Medico University of Rome
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0955: Inhibition of Interleukin-2-Inducible T Cell Kinase with Soquelitinib Demonstrates Efficacy in Preventing Lung Damage in Murine Models of Systemic SclerosisAbstract Poster Presenter: – Université Paris Cité
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0956: Secreted Frizzled-Related Protein 2 (sFRP2) Regulates Wnt Signaling to Affect Mesenchymal Transition of Lung Epithelial Cells Participates in Interstitial Lung DiseaseAbstract Poster Presenter: – West China Hospital of Sichuan University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0957: Increased Collagen Deposition and Altered Immune Cell Profiles Are Present in Early and Late Stage Systemic Sclerosis with Gastrointestinal InvolvementAbstract Poster Presenter: – Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0958: TCR Motifs Identify Unique Clones in African Americans with Systemic SclerosisAbstract Poster Presenter: – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0959: Radiomics Non-Invasively Conveys Time-Resolved Molecular Pathway Activity in Experimental Fibrosing Interstitial Lung DiseaseAbstract Poster Presenter: – University Hospital Bern
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0960: The Esophageal Epithelium in Systemic Sclerosis: Cellular and Molecular Dysregulation Revealed by Single-Cell RNA SequencingAbstract Poster Presenter: – Northwestern University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0961: Multi-omics Study of Systemic Sclerosis Immunoglobulins G Effects on Endothelial Cells: A Distinct Profile in Anti-Topoisomerase I Positive PatientsAbstract Poster Presenter: – INFINTE U186 inserm, univeristy of Lille
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0962: Characterizing the Contribution of Myeloid Cells to Limited and Diffuse Cutaneous Systemic SclerosisAbstract Poster Presenter: – Feinberg School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0963: Stratification According to Autoantibody Status in Systemic Sclerosis Reveals Distinct Molecular SignaturesAbstract Poster Presenter: – CHRU Brest
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0964: Engaging the PD-1 Pathway Attenuates Inflammation Associated Fibrosis in Systemic Sclerosis Fibroblasts and a Preclinical Mouse ModelAbstract Poster Presenter: – Aarhus University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0965: Scleroderma Associated Interstitial Lung Disease Is Characterized by Aberrant Lung Epithelial RemodelingAbstract Poster Presenter: – UCSF
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0966: CDDO-Me Attenuates Pro-fibrotic Activation in Macrophages and Fibroblasts in Systemic SclerosisAbstract Poster Presenter: – Dartmouth College
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0967: Transcriptional Heterogeneity of Immune Cells in the Esophagus of Systemic Sclerosis Patients: A Comparison of Upper and Lower Esophageal RegionsAbstract Poster Presenter: – Northwestern University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0968: Proteomic, Transcriptomic, and Functional Characterization of Circulating Extracellular Vesicles in Progressive Scleroderma Interstitial Lung DiseaseAbstract Poster Presenter: – Catholic University of the Sacred Heart
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0969: Role and Mechanism of the Wnt3a-FZD5 Pathway in Regulating the Transformed Intermediate State of Alveolar Epithelial Cells Involved in Pulmonary Fibrosis in Systemic SclerosisAbstract Poster Presenter: – zhejiang university
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0970: Deubiquitylase (DUB) BRCC36 Isopeptidase Complex (BRISC) Inhibitors Prevent IFNAR1 Deubiquitination to Restore Natural Type I IFN Response in AutoimmunityAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0971: Ligand-Receptor Analysis Reveals Myeloid-Mediated Pro-Inflammatory Responses and Loss of Mesenchymal Signaling Driven by TNFR1 in Experimental Pulmonary HypertensionAbstract Poster Presenter: – University of Rochester
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0972: Downregulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis via a Galectin-3/mTOR Dependent PathwayAbstract Poster Presenter: – Boston University School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time0973: Mechano-transduction via MRTF-A Pathway Is Required for Cytokine Release by Scleroderma MacrophagesAbstract Poster Presenter: – University College London
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1557: Estimation of Cardiovascular Risk in Patients with Systemic Sclerosis – Accuracy of Tools Based on SCORE and Its Modifications Compared to Ultrasound Examination of Subclinical AtherosclerosisAbstract Poster Presenter: – Institute of Rheumatology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1558: Mapping in Healthy Subjects Different Body Areas for Dermal Thickness and Skin Hardness by High Frequency Sonography and DurometryAbstract Poster Presenter: – University of Genoa
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1559: Vectorcardiography for Identification of Systemic Sclerosis Patients at Risk for Pulmonary HypertensionAbstract Poster Presenter: – Leiden University Medical Centre
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1560: Changes of Cerebral Structure and Perfusion Vary in Different Subtypes of Systemic Sclerosis: A Brain Magnetic Resonance Imaging StudyAbstract Poster Presenter: – Peking Union Medical College Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1561: Association of Large Vessel Vasculitis and Development of SSc and SSc-Associated Antibodies: Impact of Pulmonary Arterial HypertensionAbstract Poster Presenter: – Creighton University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1562: Autoantibody Associations with Disease Manifestations in Patients with Early Diffuse Cutaneous Systemic Sclerosis: The Prospective Registry of Early Systemic SclerosisAbstract Poster Presenter: – Columbia University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1563: Prevalence, Risk Factors and Associations for Osteoporosis in Postmenopausal Women with SclerodermaAbstract Poster Presenter: – Scripps Green Clinic Internal Medicine Residency
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1564: Incidence of Posttraumatic Stress Disorder Secondary to the Diagnosis of Systemic SclerosisAbstract Poster Presenter: – Toulouse Rangueil University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1565: Prevalence and Risk Factors of Lower Extremities Arterial Disease in Systemic Sclerosis: Preliminary Data from a Single Centre Multidisciplinary StudyAbstract Poster Presenter: – ASST Spedali Civili di Brescia
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1566: Comparative Analysis of Clinical Features and Outcomes in Late Onset vs. Early Onset Scleroderma Renal Crisis - A Multicenter StudyAbstract Poster Presenter: – Albany Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1567: Systemic Sclerosis Is Associated with Sub-Clinical Abnormalities in Myocardial Energetics, Perfusion and Increased FibrosisAbstract Poster Presenter: – Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom.
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1568: Distribution of Proteinuria in Scleroderma Renal Crisis: A Multi-Center StudyAbstract Poster Presenter: – Albany Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1569: Scleroderma Renal Crisis – Different Phenotypes and Patient TrajectoriesAbstract Poster Presenter: – Rheumatology Institute, Rambam Health Care Campus and The Rappaport Faculty of |Medicine, Technion
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1570: Deconvolution of the Lipidomic Signature of Very Early Diagnosis of Systemic Sclerosis (VEDOSS) and Established Disease: Lipid Biomarker Features That Predict Disease Progression in Skin and LungAbstract Poster Presenter: – AbbVie
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1571: Growth Differentiation Factor 15 Is a Serum Biomarker and Pathogenic Factor of Progressive Fibrosis in Systemic SclerosisAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1572: Associations Between the Gut Microbiota, Ultra-Processed Food Intake, and Gastrointestinal Tract Symptoms in Patients with Systemic SclerosisAbstract Poster Presenter: – David Geffen School of Medicine, UCLA
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1573: Early Scleroderma with Non-Raynaud's Symptoms Prior to Raynaud's Onset Is Associated with Rapid Progression to Diffuse Skin Disease and Joint ContracturesAbstract Poster Presenter: – UTHealth Houston Division of Rheumatology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1574: Therapeutic Strategy in Patients with Mixed Connective Tissue Disease: A Multicenter Retrospective Study in the French MCTD CohortAbstract Poster Presenter: – Université Paris Cité
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1575: Anti-U1RNP Antibodies Are Associated with a Distinct Clinical Phenotype and a Worse Survival in Patients with Systemic SclerosisAbstract Poster Presenter: – Université Paris Cité
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1576: New Patient-Reported Outcome Measures for Early Systemic Sclerosis Using the FDA Guidance on Patient Reported Outcome MeasuresAbstract Poster Presenter: – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1577: Elevated Neutrophil Extracellular Traps in Systemic Sclerosis-associated Vasculopathy and Suppression by a Synthetic Prostacyclin AnalogAbstract Poster Presenter: – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1578: Association of Systemic Sclerosis and Other Systemic Autoimmune Disease Diagnosis with Increasing Anti-RNA Polymerase III AntibodiesAbstract Poster Presenter: – University of Kansas Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1579: Exploring the Cardiovascular Complications of Pulmonary Arterial Hypertension in Individuals with Systemic SclerosisAbstract Poster Presenter: – Zucker School of Medicine at Hofstra/Northwell at Staten Island University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1580: Overt Polyautoimmunity and Its Risk Factors in a Multicenter Cohort of Systemic Sclerosis PatientsAbstract Poster Presenter: – Hospital del Mar
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1581: Neutrophil-to- lymphocyte Ratio: A Possible Biomarker for Clinical Response After Autologous Hematopoietic Stem Cell TransplantationAbstract Poster Presenter: – Bnai Zion medical center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1582: Impact of Immunosuppressive Treatment on Development and Survival in Systemic Sclerosis Associated Pulmonary Arterial Hypertension (SSc-PAH)Abstract Poster Presenter: – University College London
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1583: The Association of Weakpositive Anti-RNA Polymerase III Antibodies with the Diagnosis and Complications of Systemic Sclerosis and Other Systemic Autoimmune DiseasesAbstract Poster Presenter: – The University of Kansas Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1584: Efficacy of Tofacitinib in the Treatment of Early Diffuse Cutaneous Systemic Sclerosis: A Clinical Study in BangladeshAbstract Poster Presenter: – Central Police Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1585: Characterization of the Fecal Metabolome in Early Systemic SclerosisAbstract Poster Presenter: – UCLA
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1586: The Relationship Between the Presence, Quantity and Distribution of Cutaneous Telangiectasia and Other Vascular Manifestations of Systemic SclerosisAbstract Poster Presenter: – North Bristol NHS Trust
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1587: Predictors of Body Mass Index in an Early Systemic Sclerosis CohortAbstract Poster Presenter: – UTHealth Houston Division of Rheumatology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1588: Validation of a Lung Ultrasound Interpretation Criteria for Interstitial Lung Disease Screening in Systemic Sclerosis and Inflammatory MyopathyAbstract Poster Presenter: – Stanford University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1589: Whole Skin Gene Expression Analysis Identifies Discrete Modules That Differentiate Antinuclear Antibody Subsets in Systemic SclerosisAbstract Poster Presenter: – University of Oxford
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1590: Milder ILD with Preserved Lung Function Significantly Contributes to Respiratory Caused Mortality in SScAbstract Poster Presenter: – Oslo University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time1591: Domains and Outcome Measures for the Assessment of Digital Vasculopathy and Raynaud Phenomenon in Juvenile Systemic Sclerosis: A Systematic ReviewAbstract Poster Presenter: – Unicamp
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
1:00 PM – 2:30 PM Eastern Time17S57: Abstracts: Systemic Sclerosis & Related Disorders – Clinical ILocation: Room 147AB
Abstract Moderator: – Boston University
Abstract Moderator: – Hospital for Special Surgery
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
1:00 PM – 1:15 PM Eastern Time1689: Pulmonary Function Test Reference Equations May Drive Inequitable Classification of Restrictive Lung Disease Severity in Systemic SclerosisLocation: Room 147AB
Presenting Author: – Johns Hopkins University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
1:15 PM – 1:30 PM Eastern Time1690: FAPI-PET/CT as a Predictor of Accelerated Lung Function Deterioration in Systemic Sclerosis Related Interstitial Lung Disease (ILD): Preliminary-interim Analysis from a Confirmatory Risk Factor StudyLocation: Room 147AB
Presenting Author: – Department Internal Medicine III, Friedrich-Alexander-University (FAU) Erlangen-Nurnber
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
1:30 PM – 1:45 PM Eastern Time1691: Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung DiseaseLocation: Room 147AB
Presenting Author: – University of California, Los Angeles
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
1:45 PM – 2:00 PM Eastern Time1692: Single Cell RNA-seq Identifies Circulating Double-negative-2 B-cell Population Associated with Progressive Scleroderma Interstitial Lung DiseaseLocation: Room 147AB
Presenting Author: – Cedars-Sinai Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
2:00 PM – 2:15 PM Eastern Time1693: Change in Forced Vital Capacity at Week 12 or 24 Has Prognostic Value for Outcome at Week 52 in Patients with Autoimmune Disease-Related Interstitial Lung DiseasesLocation: Room 147AB
Presenting Author: – Oslo University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
2:15 PM – 2:30 PM Eastern Time1694: One-Year Survival Following Single versus Double Lung Transplantation in Adults with Systemic Autoimmune Rheumatic Disease-related Interstitial Lung Disease: A Nationwide Cohort StudyLocation: Room 147AB
Presenting Author: – Albert Einstein College of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
2:15 PM – 3:15 PM Eastern Time17S39: State of the Art Lecture: Precision Medicine in Systemic SclerosisLocation: Ballroom A
Moderator: – Vanderbilt University Medical Center
Moderator: – Yale School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
2:15 PM – 2:45 PM Eastern TimeMolecular Phenotypes of Systemic Sclerosis: Data-driven Approaches to Managing Clinical Manifestations of Systemic SclerosisLocation: Ballroom A
Speaker: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
2:45 PM – 3:15 PM Eastern TimeFunctional Response Biomarkers for SSc-ILD: Using Molecular Imaging and Other Biomarkers to Guide Treatment DecisionsLocation: Ballroom A
Speaker: – University of California, Los Angeles
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
3:30 PM – 4:30 PM Eastern Time17S45: Great Debate: MCTD: Is It Just Letters?Location: Hall D/E
Moderator: – University of Calgary
Moderator: – Johns Hopkins School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
3:30 PM – 3:45 PM Eastern TimeMCTD Is a Unique Rheumatic DiseaseLocation: Hall D/E
Interactive Speaker: – Johns Hopkins University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
3:45 PM – 4:00 PM Eastern TimeMCTD Is Not a Unique Rheumatic DiseaseLocation: Hall D/E
Interactive Speaker: – New York University Grossman School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
4:00 PM – 4:10 PM Eastern TimeMCTD Is a Unique Rheumatic Disease - RebuttalLocation: Hall D/E
Interactive Speaker: – Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
4:10 PM – 4:20 PM Eastern TimeMCTD Is Not a Unique Rheumatic Disease - RebuttalLocation: Hall D/E
Interactive Speaker: – Oklahoma Medical Research Foundation
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Sunday, Nov 17th
4:20 PM – 4:30 PM Eastern TimeGreat Debate: Q & ALocation: Hall D/E
Panelist: – Johns Hopkins University
Panelist: – New York University Grossman School of Medicine
Panelist: – Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
Panelist: – Oklahoma Medical Research Foundation
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
7:30 AM – 8:30 AM Eastern TimeMTP16A: Meet the Professor: IgG4-Related DiseaseLocation: Room 155
Seminar Presenter: – Massachusetts General Hospital , Harvard Medical School
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
7:30 AM – 8:30 AM Eastern TimeMTP19A: Meet the Professor: Systemic SclerosisLocation: Room 153
Seminar Presenter: – University of Western Ontario
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
9:00 AM – 10:30 AM Eastern Time18M11: Optimizing the Management of Skin Disease in Systemic Sclerosis: Using Clinical Features and Novel Disease Activity Measures to Guide Treatment DecisionsLocation: Room 150AB
Moderator: – UCLA
Moderator: – Johns Hopkins University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
9:00 AM – 9:30 AM Eastern TimeSkin Treatment in Scleroderma: Using Clinical Data to Optimize Treatment DecisionsLocation: Room 150AB
Speaker: – University of Pittsburgh
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
9:30 AM – 10:00 AM Eastern TimeCan Novel Diagnostics Inform Early Intervention Decisions for Preventing Skin Fibrosis?Location: Room 150AB
Speaker: – Radboud University Nijmegen Medical Centre
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:00 AM – 10:30 AM Eastern TimeAutologous Stem Cell Transplantation for Skin Involvement in SScLocation: Room 150AB
Speaker: – Duke University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern TimeSystemic Sclerosis & Related Disorders – Basic Science Poster IIFibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern TimeSystemic Sclerosis & Related Disorders – Clinical Poster IIIFibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1814: Understanding Monocyte Derived Macrophages in the Skin of SSc Patients Through Single Cell Analysis of Blister Fluid Immune Cell PopulationsAbstract Poster Presenter: – University College London
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1815: Leveraging Novel Systemic Sclerosis Disease Signatures to Build a Humanized Drug Discovery FunnelAbstract Poster Presenter: – AbbVie
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1816: Paracrine WNT Signaling Drives Pro-fibrotic Metabolic Activation of Systemic Sclerosis MacrophagesAbstract Poster Presenter: – Dartmouth College
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1817: Activated Macrophages Mediate Loss of Dermal White Adipose Tissue in Fibrotic SkinAbstract Poster Presenter: – Geisel School of Medicine at Dartmouth
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1818: Distribution and Morphological Changes of Adventitial Fibroblasts in Healthy and Scleroderma SkinAbstract Poster Presenter: – UPMC-Mercy
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1819: Insulin-like Growth Factor Binding Protein-7 (IGFBP7) Plays a Pathogenic Role in Dermal Fibrosis and Is Increased in Systemic SclerosisAbstract Poster Presenter: – University of Rochester Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1820: Disruption of Ca2+ Homeostasis and Enhanced Ca2+ Signaling in Scleroderma Fibroblasts Is Due to the Vicious Cycle Formed by Mitochondrial-derived Reactive Oxygen Species, CaMKII, and ER Extrusion Pump RYR2Abstract Poster Presenter: – Division of Rheumatology, Department of Internal Medicine, University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1821: Single-Cell RNA SequencingBioinformatic Pipeline Optimized for Non-Coding GenesIdentified LINC01503 and MIR193-BHG as Potential Pathogenic Effectors in Systemic Sclerosis FibroblastsAbstract Poster Presenter: – University of Zurich
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1822: Analysis of Differential Activation of Lysophosphatidic Acid Regulated Genes in Diffuse and Limited Cutaneous Systemic SclerosisAbstract Poster Presenter: – Royal Free Hospital, London UK
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1823: Identification and Prediction of Systemic Sclerosis Intrinsic Subtypes Using Semi-Supervised and Supervised Learning on Gene Expression Data of Multiple CohortsAbstract Poster Presenter: – Dartmouth College
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1824: Skin Macrophage Subtypes and Impact of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis: Results from Single-cell Analyses of an Observational Data Set and a Phase I/II Randomized Controlled TrialAbstract Poster Presenter: – CHU Rennes - University Rennes
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1825: Proteomic and Transcriptomic Analysis Reveal Elevated Senescent Signature in Systemic Sclerosis FibrosisAbstract Poster Presenter: – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1826: Unveiling the Primary Cilia Signature Driving Systemic Sclerosis PathogenesisAbstract Poster Presenter: – Virginia Commonwealth University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1827: Characterization of Fibroblast Subpopulations and Their Cellular Local Environments in Systemic Sclerosis Using Imaging Mass CytometryAbstract Poster Presenter: – University Hospital of Düsseldorf
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1828: SSc Fibroblasts Trigger a Systemic Type I Interferon Response in SSc Patients Through Canonical TGF-β Receptor SignallingAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1829: Genomic Analysis of Skin Biopsies Differentiates Major Anti-Nuclear Autoantibody Subsets in Limited Cutaneous Systemic SclerosisAbstract Poster Presenter: – UCL
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1830: Single-cell RNA Sequencing Profiling of Very Early-Stage Systemic Sclerosis Skin Reveals a Fibroblast Pro-inflammatory Gene Signature and Keratinocyte DysregulationAbstract Poster Presenter: – Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1831: Role of Long Non-Coding RNA H19 in Mediating Skin Fibrosis in Systemic SclerosisAbstract Poster Presenter: – Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1832: Targeting Hippo Pathway Diminishes Disease Signaling in Scleroderma SkinAbstract Poster Presenter: – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1833: Immune Complexes of Antibodies Directed to Angiotensin Receptor type-1 and Extracellular Vesicles Are Unique Modulators Contributing to Systemic SclerosisAbstract Poster Presenter: – Department of Rheumatology and Clinical Immunology, University of Lübeck
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time1834: Altered Mechanotransduction via Myosin II Contributes to Collagen and IL-6 Production in Systemic Sclerosis SkinAbstract Poster Presenter: – Hopitaux Universitaire de Geneva
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2441: Investigating Kidney Disease Risks in Systemic Sclerosis (SSc) – Effects of Proton Pump Inhibitors (PPI): Retrospective AnalysisAbstract Poster Presenter: – Jefferson Einstein Philadelphia Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2442: Clustering Algorithm as an Exploratory Analysis of Different Clinical Phenotypes in Systemic Sclerosis. Data from the PRECISESADS StudyAbstract Poster Presenter: – H. U. Reina Sofía
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2443: The Clinical Phenotype of Anti-Th/To+ Patients in Systemic Sclerosis: A Case-control Study Within the European Scleroderma Trials and Research (EUSTAR) CohortAbstract Poster Presenter: – Rheumatology Unit ASST Spedali Civili and University of Brescia
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2444: Performance of the DETECT Algorithm and Cluster Analysis in Screening for Systemic Sclerosis Pulmonary Hypertension GroupsAbstract Poster Presenter: – Johns Hopkins University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2445: Effects of Aminaphtone on TGF-beta1 Serum Concentration as Concomitant Treatment to Standard Therapy in Systemic Sclerosis Patients: A Pilot StudyAbstract Poster Presenter: – Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2446: Nailfold Videocapillaroscopy Findings in Patients with Limited Cutaneous versus Diffuse Cutaneous Systemic Sclerosis: The First Detailed Retrospective StudyAbstract Poster Presenter: – Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2447: Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter CohortAbstract Poster Presenter: – APHP
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2448: Content Validity and Sensitivity to Change of ScleroID Through the Natural History of Scleroderma. a Validated Tool to Measure the Impact of SSc on How Patients Feel and FunctionAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2449: Acid Reflux Triggers Type I Interferon and Persistent Epithelial-mesenchymal Transition in Esophageal Epithelial Cells. a Novel Microenvironment Contribution to the Pathogenesis of Systemic SclerosisAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2450: Disease Progression in Anti-Centromere Positive Systemic Sclerosis PatientsAbstract Poster Presenter: – Leiden University Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2451: Prognostic Value of Functional Outcomes in a Italian Multicentric Cohort of Early SSc-ILD PatientsAbstract Poster Presenter: – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2452: Multimodal Ultrasound in the Assessment of Sarcopenia-related Muscle Involvement in Patients with Systemic Sclerosis: A Multicentric StudyAbstract Poster Presenter: – University of Verona
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2453: Gastrointestinal Symptom Severity and Intestinal Permeability in Systemic Sclerosis: A Single Center Prospective StudyAbstract Poster Presenter: – Mayo Clinic, Rochester, MN
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2454: Age-Adjusted Mortality Rate Trends in Systemic Sclerosis in the United States from 1999 to 2020Abstract Poster Presenter: – Case Western Reserve University/University Hospitals
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2455: Improvement Across Multi-organ Domains and Patient Reported Outcomes in Refractory Juvenile-Onset Systemic Sclerosis (jSSc) up to 4 Years After Autologous Stem Cell Transplantation (ASCT)Abstract Poster Presenter: – Division of Rheumatology, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2456: High Levels of Circulating IFNα Are Associated with Increased Mortality in Patients with Diffuse Cutaneous Systemic SclerosisAbstract Poster Presenter: – AP HP
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2457: Polypharmacy, Drug-drug Interactions, and Adverse Drug Reactions Among Systemic Sclerosis Patients: A Cross-sectional Risk Factor StudyAbstract Poster Presenter: – Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes et Autoinflammatoires Rares d'Ile de France de l’Est et de l’Ouest, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP)
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2458: Risk Factors for Progression of Interstitial Lung Disease in Patients with Early Diffuse Cutaneous Systemic SclerosisAbstract Poster Presenter: – Columbia University Irving Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2459: Use of Nailfold Capillaroscopy as a Predictor of Cardiovascular Events and Mortality in Systemic SclerosisAbstract Poster Presenter: – Hospital Universitario Doctor Peset
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2460: Severe Gastrointestinal Involvement in Systemic Sclerosis: A New “Transversal” Subset of Disease to Be Prioritised for Intervention TrialsAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2461: Prevalence and Impact of Peripheral Neuropathy in SSc: A Frequent and Disabling Manifestation in SSc, and a Potential Surrogate Marker for Autonomic NeuropathyAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2462: A Potent Inhibitor of PAI-1, MDI-2517, Mitigates Disease Severity in Preclinical Models of Systemic SclerosisAbstract Poster Presenter: – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2463: Interstitial Lung Disease in Very Early Systemic Sclerosis – a Clinical and Radiological CharacterizationAbstract Poster Presenter: – University of Zurich, University Hospital Zurich
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2464: Thymic Size Longitudinal Changes on Chest High-resolution Computed Tomography After Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic SclerosisAbstract Poster Presenter: – Toulouse Rangueil University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2465: Subclinical Loss of Lung Volumes in Very Early SSc: Evidence from Two Independent Cohorts in EUSTARAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2466: Ranked Composite Important Difference (RCID) Scores in Patients with Diffuse Cutaneous Systemic Sclerosis and Interstitial Lung DiseaseAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2467: Elderly Systemic Sclerosis. Clinical Presentation and OutcomeAbstract Poster Presenter: – Complejo Asistencial Universitario de León
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2468: Audio-Guided Imagery Positively Impacted Patients with Raynaud's Phenomenon Associated Connective Tissue DiseaseAbstract Poster Presenter: – University of Pittsburgh Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2469: Machine Learning Identifies Oesophageal Symptoms as a New Red Flag for for Very Early Diagnosis of Systemic Sclerosis (VEDOSS): A EUSTAR AnalysisAbstract Poster Presenter: – University of Leeds
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2470: Progression Patterns in Systemic Sclerosis - Associated Interstitial Lung DiseasesAbstract Poster Presenter: – Université Paris Cité
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2471: Association of Telangiectasias with Autoantibodies and Clinical Manifestations in Systemic SclerosisAbstract Poster Presenter: – University of Pittsburgh Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2472: Are Anti-centromere Antibodies (aCENP) Predictive of Systemic Sclerosis Development in Patients Without Raynaud´s Phenomenon?Abstract Poster Presenter: – Fundacion Jimenez Diaz Univ. Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2473: Criterion Validity of Modified Rodnan Skin Score: Does It Capture Skin Thickness or Hardening? Results of a Large Skin Histology StudyAbstract Poster Presenter: – UTHealth Houston Division of Rheumatology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2474: High-throughput Screening Identifies Specific Molecular Markers for ILD in Patients with Rheumatic DiseasesAbstract Poster Presenter: – Oslo University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2475: The Critical Role of Annual HRCT in Identifying ILD Progression and Assessing Outcome in SScAbstract Poster Presenter: – Oslo University Hospital
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2476: The Impact of Systemic Sclerosis Manifestations on Survival and Humanistic Burden: A Targeted Literature ReviewAbstract Poster Presenter: – University of California, Los Angeles
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time2477: Quantifying Tissue Microstructural Changes in Scleroderma Skin Using a Novel, Point-of-care, High-frequency-ultrasound InstrumentAbstract Poster Presenter: – Hospital for Special Surgery
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
11:30 AM – 12:30 PM Eastern TimeMTP16B: Meet the Professor: IgG4-Related DiseaseLocation: Room 155
Seminar Presenter: – Massachusetts General Hospital , Harvard Medical School
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
11:30 AM – 12:30 PM Eastern TimeMTP19B: Meet the Professor: Systemic SclerosisLocation: Room 153
Seminar Presenter: – University of Western Ontario
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
1:00 PM – 2:30 PM Eastern Time18M34: Gasping for Cellular Repair: New Insights Into Interstitial Lung Disease Pathogenesis and TreatmentLocation: Room 143ABC
Moderator: – Division of Rheumatology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Moderator: – UCSF
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
1:00 PM – 1:30 PM Eastern TimeNew Insights into Biomarkers and Biology of Systemic Sclerosis-ILDLocation: Room 143ABC
Speaker: – UTHealth Houston Division of Rheumatology
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
1:30 PM – 2:00 PM Eastern TimeVascular-Parenchymal Crosstalk in ILDLocation: Room 143ABC
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
2:00 PM – 2:30 PM Eastern TimePipeline to Developing New ILD TherapiesLocation: Room 143ABC
Speaker: – Yale School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
2:15 PM – 3:15 PM Eastern Time18M38: CARE to Test Your Knowledge: Scleroderma Renal CrisisLocation: Ballroom C
Moderator: – Medical University of South Carolina
Moderator: – Georgetown University School of Medicine
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
2:15 PM – 3:15 PM Eastern TimeCARE: Scleroderma Renal CrisisLocation: Ballroom C
Speaker: – University College London
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
3:00 PM – 4:30 PM Eastern Time18M70: Abstracts: Systemic Sclerosis & Related Disorders – Clinical IILocation: Room 207AB
Abstract Moderator: – UTHealth Houston Division of Rheumatology
Abstract Moderator: – University of Pittsburgh Medical Center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
3:00 PM – 3:15 PM Eastern Time2641: Identification of Systemic Sclerosis Intrinsic Subtypes in the ASSET Clinical Trial Using PBC Gene ExpressionLocation: Room 207AB
Presenting Author: – Geisel School of Medicine at Dartmouth
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
3:15 PM – 3:30 PM Eastern Time2642: Identifying Systemic Sclerosis Molecular Subtypes by Their Cellular Signature – Deconvoluting the PuzzleLocation: Room 207AB
Presenting Author: – Bnai Zion medical center
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
3:30 PM – 3:45 PM Eastern Time2643: Integrated Bulk and Single Cell RNA Sequencing Defines Key Pathways Regulating Myofibroblast Differentiation Across ANA Subgroups in Diffuse Systemic SclerosisLocation: Room 207AB
Presenting Author: – University of Oxford
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
3:45 PM – 4:00 PM Eastern Time2644: Baseline Fibroblast Immunophenotype Predicts Clinical Improvement Among Individuals with Early Diffuse Cutaneous Systemic SclerosisLocation: Room 207AB
Presenting Author: – Hospital for Special Surgery
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
4:00 PM – 4:15 PM Eastern Time2645: Human NCF1-p.R90H Variant Promotes Pulmonary Fibrosis in the Bleomycin-induced Mouse Model and Systemic Sclerosis Patients via Expansion of SPP1+Monocytes-derived MacrophagesLocation: Room 207AB
Presenting Author: – Medical University of South Carolina/Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Monday, Nov 18th
4:15 PM – 4:30 PM Eastern Time2646: Rare Variants in the IL1RAP Gene Implicate the IL-1 Signaling Pathway in the Pathogenesis of Systemic Sclerosis in African and European AncestriesLocation: Room 207AB
Presenting Author: – Scleroderma Genomics and Health Disparities Unit, NIAMS, NIH
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Tuesday, Nov 19th
11:00 AM – 12:30 PM Eastern Time19T16: Abstracts: Systemic Sclerosis & Related Disorders – Clinical IIILocation: Room 102AB
Abstract Moderator: – Stanford University
Abstract Moderator: – Pontificia Universidad Catolica de Chile
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Tuesday, Nov 19th
11:00 AM – 11:15 AM Eastern Time2683: Optical Coherence Angiography: A Non-invasive, Safe Method for Assessing the Systemic Sclerosis Related Vasculopathy Beyond Nailfold CapillariesLocation: Room 102AB
Presenting Author: – University of Houston
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Tuesday, Nov 19th
11:15 AM – 11:30 AM Eastern Time2684: Assessment of Skin in Patients with Systemic Sclerosis Using High Frequency Ultrasound : A Comparative Study with Histology and Clinical Parameters of Skin DiseaseLocation: Room 102AB
Presenting Author: – EVMS
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Tuesday, Nov 19th
11:30 AM – 11:45 AM Eastern Time2685: Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium ProjectLocation: Room 102AB
Presenting Author: – UCLA
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Tuesday, Nov 19th
11:45 AM – 12:00 PM Eastern Time2686: Dose Escalation Safety Study of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis:Clinical Results and Mechanistic Analysis of Skin and Peripheral Blood Mononuclear CellsLocation: Room 102AB
Presenting Author: – University of Michigan
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Tuesday, Nov 19th
12:00 PM – 12:15 PM Eastern Time2687: Therapeutic Choices in Systemic Sclerosis Associated Interstitial Lung Disease, a Survey of International ExpertsLocation: Room 102AB
Presenting Author: – University of Chicago
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
-
Tuesday, Nov 19th
12:15 PM – 12:30 PM Eastern Time2688: HLA-DRB4: A Novel Susceptibility Locus in Systemic Sclerosis Patients with Severe CalcinosisLocation: Room 102AB
Presenting Author: – UCSF
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)